---
$id: https://graph.org.ai/products/commodity/51143209
$type: Product
source: UNSPSC
code: "51143209"
title: "Acamprosate calcium"
class: "51143200"
classTitle: "Anti abuse drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acamprosate calcium

**UNSPSC Code**: 51143209
**Class**: [Anti abuse drugs](Anti abuse drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula 2C5H10NO4S.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59375N1D0U, chemically known as 1-propanesulfonic acid, 3-(acetylamino)-, calcium salt (2:1) but more generally known as acamprosate calcium, which bears US NIH Compound Identifier 155434. European Medicines Agency schedules Acamprosate calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00239MIG. Most nations, for tariff and trade purposes, schedule acamprosate calcium under HS 29241900 and SITC 51471. As of Q4 2014, ACAMPROSATE CALCIUM remains US FDA's Preferred Term for this commodity. Acamprosate calcium bears US NLM identifiers UMLS ID C0592789 and NCI Concept Code C65209. SMILES: CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[CA+2].

